Pant et al., 2002 - Google Patents
Noninvasive colorectal cancer screeningPant et al., 2002
- Document ID
- 8372144168069291680
- Author
- Pant K
- McCracken J
- Publication year
- Publication venue
- Digestive diseases and sciences
External Links
Snippet
Abnormal mucin with the STn epitope is produced by colorectal cancer cells and is immunologically distinguishable from normal colonic mucin. Herein we describe a technique of detecting abnormal mucin in fecal samples as a method of screening for colorectal …
- 201000011231 colorectal cancer 0 title abstract description 15
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
Similar Documents
Publication | Publication Date | Title |
---|---|---|
O’brien et al. | Immunocytochemical Localization of Carcinoembryonic Antigen in Benign and Malignant Colorectal Tissues: Assessment of Diagnostic Value. | |
CN103476428B (en) | For diagnosing blood markers thing and the monoclonal antibody thereof of epitheliogenic cancerg | |
KR920010296B1 (en) | In Vitro Diagnosis of Gastrointestinal Cancer | |
JP2002525632A (en) | YKL-40 as a marker and prognostic indicator for cancer | |
CN112345755A (en) | Biomarker of breast cancer and application thereof | |
US5646002A (en) | Method for increasing the sensitivity of assays for target ligand | |
CN101539574B (en) | Application of Survivin antibody and esophageal cancer immunochromatography detecting test strip prepared therewith | |
WO1983004311A1 (en) | Process for preparing fucose antigen and antibody for distinguishing it, measurement of tumor-associated sugar chain utilizing the same, and kit for the measurement | |
CN111879924A (en) | Colloidal gold immunochromatography test paper for rapidly diagnosing hemoglobin and combining globin-hemoglobin compound and preparation method thereof | |
Tatsuta et al. | Carcinoembryonic antigen in the bile in patients with pancreatic and biliary cancer correlation with cytology and percutaneous transhepatic cholangiography | |
US6531319B1 (en) | Method of detecting colon cancer | |
Pant et al. | Noninvasive colorectal cancer screening | |
US20200400673A1 (en) | Methods for cancer detection by evaluation of glycan-binding patterns of immunoglobulins in gastrointestinal lavage fluid samples | |
CN109116023A (en) | A kind of lung cancer marker anti-MM P12 autoantibody and its application | |
Muretto et al. | An endogastric capsule for measuring tumor markers ingastric juice: An evaluation of the safety and efficacy of a new diagnostic tool | |
WO2002077649A1 (en) | Method of diagnosing breast cancer | |
Frykholm et al. | Expression of the carcinoma-associated antigens CA 19-9 and CA-50 in inflammatory bowel disease | |
Tobi et al. | Increased expression of a putative adenoma-associated antigen in pre-colonoscopic effluent of patients with colorectal cancer | |
Vider et al. | Carcinoembryonic antigen (CEA) monitoring in the management of radiotherapeutic patients | |
Pesce et al. | Immune complexes in transitional cell carcinoma | |
Tsuji et al. | Identification of an H antigen-like blood group antigen in sera of cancer patients using a novel monoclonal antibody raised against endometrial carcinoma | |
Tobi et al. | Adenoma-derived antibody, Adnab-9 recognizes a membranebound glycoprotein in colonic tissue and effluent material from patients with colorectal neoplasia | |
US20050106642A1 (en) | Saliva test for early diagnosis of cancers | |
Zamcheck et al. | lignant Diseases of the Digestive Tract¹, 2, 3 | |
CN113267626B (en) | Test strip for early screening of cardia adenocarcinoma of high risk group |